Intramuscular administration of recombinant human c1-inhibitor could be an alternative for the treatment of acute attacks in patients with hereditary angioedema: A 3 year experience
2018 ◽
Vol 141
(2)
◽
pp. AB58
2011 ◽
Vol 127
(2)
◽
pp. AB101-AB101
◽
Keyword(s):
2008 ◽
Vol 45
(16)
◽
pp. 4118-4119
◽
Keyword(s):
2008 ◽
Vol 121
(3)
◽
pp. 797
◽
2018 ◽
Vol 141
(2)
◽
pp. AB56
2013 ◽
Vol 108
◽
pp. S101-S102
2005 ◽
Vol 59
(5)
◽
pp. 594-599
◽
Keyword(s):